Pulmonary Arterial Hypertension Market Driven by Obesity & Cardiopulmonary Disorders | Report by DataM Intelligence
Pulmonary Arterial Hypertension Market to hit $10.6 Billion by 2031 at 5.3% CAGR, driven by drug innovation and rising PAH prevalence. AUSTIN, TX, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- The Pulmonary Arterial Hypertension (PAH) …